bpc-157 peptide safety regulatory status FDA may take an important step toward opening the floodgates this week A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

SKU: 75704362885 · From equiscorp.hu